Demand Generation I-Kit for Underutilized, Life Saving Commodities

Spotlight on Antenatal Corticosteroids for Preterm Respiratory Distress Syndrome

Studies have found that the antenatal corticosteroid (ACS) injection for women at risk of preterm delivery is the most effective intervention to reduce the risk of Respiratory Distress Syndrome (RDS) for preterm babies, and is the standard of care in most high-income countries—reducing neonatal mortality by 31 percent and moderate/severe RDS by 45 percent. Unfortunately, in middle- and low-income, high-burden countries, ACS coverage is only 10 percent.

As such, it has been identified by the UN Commission on Life-Saving Commodities for Women’s and Children’s Health as one of 13 commodities that if more widely accessed and properly used, could save the lives of more than six million women and children worldwide.

Copyright © Johns Hopkins University, All Rights Reserved

USAID LogoThis website is made possible by the support of the American People through the United States Agency for International Development (USAID) under the Health Communication Capacity Collaborative (HC3) Cooperative Agreement #AID-OAAA-A-12-00058. On-going support is provided by Breakthrough ACTION with support from USAID’s Bureau for Global Health, under Cooperative Agreement #AID-OAA-A-17-00017. Breakthrough ACTION is based at the Johns Hopkins Center for Communication Programs (CCP). The contents of this website are the sole responsibility of Breakthrough ACTION and do not necessarily reflect the views of USAID, the United States Government, or the Johns Hopkins University.